Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $192,640 - $216,958
1,400 New
1,400 $216,000
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $3.45 Million - $4.29 Million
-26,000 Reduced 96.3%
1,000 $134,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $2.89 Million - $3.33 Million
20,000 Added 285.71%
27,000 $4.3 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $2.2 Million - $2.64 Million
-15,900 Reduced 69.43%
7,000 $1.13 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $3.07 Million - $3.52 Million
22,900 New
22,900 $3.07 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $591,466 - $740,050
-8,200 Reduced 35.96%
14,600 $1.29 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $3.31 Million - $4.23 Million
-50,400 Reduced 68.85%
22,800 $1.66 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $5.65 Million - $6.65 Million
73,200 New
73,200 $5.9 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $3.9 Million - $4.81 Million
-50,100 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $4.13 Million - $4.6 Million
46,500 Added 1291.67%
50,100 $4.74 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $4.69 Million - $5.15 Million
-52,400 Reduced 93.57%
3,600 $348,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $3.91 Million - $5 Million
56,000
56,000 $4.98 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.